Advertisement

Topics

Alexion Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 01052018] Prices from USD $175

02:34 EDT 9 Aug 2018 | BioPortfolio Reports

Alexion Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report


Summary


Alexion Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360 view of the company.


Key Highlights


Alexion Pharmaceuticals Alexion or 'the company' is a biopharmaceutical company engaged in the innovation, development and commercialization of lifetransforming therapeutic products. The company primarily operates in the US, Europe and Asia Pacific. It is headquartered in Cheshire, Connecticut, and employed 2,924 people as on December 31, 2015.


Scope


Detailed information on Alexion Pharmaceuticals, Inc. required for business and competitor intelligence needs

A study of the major internal and external factors affecting Alexion Pharmaceuticals, Inc. in the form of a SWOT analysis

An indepth view of the business model of Alexion Pharmaceuticals, Inc. including a breakdown and examination of key business segments

Intelligence on Alexion Pharmaceuticals, Inc.'s mergers and acquisitions MandA, strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

News about Alexion Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins

Large number of easytograsp charts and graphs that present important data and key trends


Reasons to buy


Gain understanding of Alexion Pharmaceuticals, Inc. and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Alexion Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Alexion Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Original Article: Alexion Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 01052018] Prices from USD $175

NEXT ARTICLE

More From BioPortfolio on "Alexion Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 01052018] Prices from USD $175"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.